Powerpack

Unlock full stockrow access for only $9.90/month and boost yourself as an investor.

  • Full quarterly history

    Every quarter and TTM period we hold, not just the last 12.

  • Analyst estimates

    Three years of forward estimates and dividend forecasts.

  • Unlimited screener

    All results, unlimited saved screens, email when a screen changes.

  • Unlimited Excel

    Full workbooks and screener exports.

  • Unlimited follows

See Powerpack
Screener Weekly Summary Pricing

Labcorp Holdings Inc. (LH) vs Revvity Inc. (RVTY)

Labcorp Holdings Inc. and Revvity Inc. are both Diagnostics & Research companies. Labcorp Holdings Inc. is the larger, with a market value of $21.9B against $16.8B — 1.3× the size. Labcorp Holdings Inc. trades at the lower P/E: 25.4× against 72.0×. Labcorp Holdings Inc. grew revenue faster over the last twelve months: 6.41% against 4.05%. Revvity Inc. has the higher net margin (8.16% vs 6.99%) and the lower return on invested capital (2.38% vs 6.50%). Both pay a dividend; Labcorp Holdings Inc. yields more (0.98% vs 0.27%). Across the 23 metrics below, Labcorp Holdings Inc. leads on 15 and Revvity Inc. on 8.

Valuation

Metric LH RVTY Diagnostics & Research median
P/E 25.44 71.96 33.95
P/S 1.76 5.79 4.87
P/B 2.94 2.33 3.12
Price to free cash flow 24.51 29.84 34.02
EV/EBITDA 14.70 24.55 25.20
EV/Sales 2.25 6.54 5.66
Earnings yield 3.93% 1.39% (1.75%)
Free cash flow yield 4.08% 3.35% (0.13%)

Profitability

Metric LH RVTY Diagnostics & Research median
Gross margin 28.88% 54.98% 50.89%
Operating margin 10.43% 12.32% (8.57%)
Net margin 6.99% 8.16% (6.37%)
Free cash flow margin 8.16% 19.58% 0.00%
Return on equity 11.74% 3.21% (2.92%)
Return on assets 5.48% 1.95% (6.71%)
Return on invested capital 6.50% 2.38% 0.00%

Growth

Metric LH RVTY Diagnostics & Research median
Revenue growth (TTM) 6.41% 4.05% 7.69%
EPS growth (last fiscal year) 18.33% (5.91%) —
Revenue growth, 5-year CAGR (0.04%) 1.41% 7.40%
Net income growth, 5-year CAGR (10.85%) (19.82%) 0.00%

Health

Metric LH RVTY Diagnostics & Research median
Debt to equity 0.69 0.44 0.11
Current ratio 1.80 1.80 2.02
Net debt to EBITDA 2.23 3.00 0.78

Dividend

Metric LH RVTY Diagnostics & Research median
Dividend yield 0.98% 0.27% 0.70%
Payout ratio 0.27 0.05 0.00

Size

Metric LH RVTY Diagnostics & Research median
Market cap 21.86b 16.81b 2.56b

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack